Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Malignant pleural effusion: further translational research is crucial.

Literature DB >> 25806178

Malignant pleural effusion: further translational research is crucial.

Yasuhiko Nishioka¹.

Abstract

Entities: Disease

Year: 2012 PMID： 25806178 PMCID： PMC4367564 DOI： 10.3978/j.issn.2218-6751.2012.09.06

Source DB: PubMed Journal: Transl Lung Cancer Res ISSN： 2218-6751

Keyword Cloud
References

× No keyword cloud information.

24 in total

1. Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice.

Authors: S Yano; H Nokihara; M Hanibuchi; P Parajuli; T Shinohara; T Kawano; S Sone
Journal: Oncol Res Date: 1997 Impact factor: 5.574

2. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

Authors: Georgios T Stathopoulos; Taylor P Sherrill; Sophia P Karabela; Kasia Goleniewska; Ioannis Kalomenidis; Charis Roussos; Barbara Fingleton; Fiona E Yull; R Stokes Peebles; Timothy S Blackwell
Journal: Am J Respir Crit Care Med Date: 2010-07-01 Impact factor: 21.405

3. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

Authors: Georgios T Stathopoulos; Zhiwen Zhu; M Brett Everhart; Ioannis Kalomenidis; William E Lawson; Semra Bilaceroglu; Todd E Peterson; Daphne Mitchell; Fiona E Yull; Richard W Light; Timothy S Blackwell
Journal: Am J Respir Cell Mol Biol Date: 2005-10-06 Impact factor: 6.914

Review 4. Pleurodesis for malignant pleural effusions.

Authors: P Shaw; R Agarwal
Journal: Cochrane Database Syst Rev Date: 2004

5. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.

Authors: Kenji Ikuta; Seiji Yano; Van The Trung; Masaki Hanibuchi; Hisatsugu Goto; Qi Li; Wei Wang; Tadaaki Yamada; Hirokazu Ogino; Soji Kakiuchi; Hisanori Uehara; Yoshitaka Sekido; Toshimitsu Uenaka; Yasuhiko Nishioka; Saburo Sone
Journal: Clin Cancer Res Date: 2009-11-24 Impact factor: 12.531

6. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.

Authors: Georgios T Stathopoulos; Ioannis Psallidas; Ardiana Moustaki; Charalampos Moschos; Androniki Kollintza; Sophia Karabela; Ilias Porfyridis; Spyridoula Vassiliou; Marilena Karatza; Zongmin Zhou; Myungsoo Joo; Timothy S Blackwell; Charis Roussos; Daniel Graf; Ioannis Kalomenidis
Journal: J Natl Cancer Inst Date: 2008-10-07 Impact factor: 13.506

Malignant pleural effusion: further translational research is crucial.

1. Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice.

2. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

3. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

Review 4. Pleurodesis for malignant pleural effusions.

5. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.

6. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.

7. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.

Review 8. Advances in the systemic therapy of malignant pleural mesothelioma.

9. Mesotheliomas in rats following inoculation with asbestos.

10. BCG treatment of malignant pleural effusions in the rat.